Hi-Tech Pharmaceuticals Halodrol

£61.15

In Stock

Description

What Is Hi-Tech Pharmaceuticals Halodrol?

Hi-Tech Pharmaceuticals Halodrol contains a 250mg blend including 1-androsterone (1-Andro), 4-androsterone (4-Andro) and androsterone, together with Rhaponticum carthamoides extract. It is supplied as 30 capsules.

The formula is positioned for athletes focused on muscle definition and vascularity.

Key Benefits

  • 250mg Blend: Combines 1-Andro, 4-Andro and androsterone in one serving.
  • Unmethylated Compounds: The description identifies 1-Andro and 4-Andro as unmethylated.
  • Rhaponticum Carthamoides: A plant extract containing naturally occurring ecdysteroids.
  • Definition Focus: Designed for a lean, defined physique without water retention.
  • Hi-Tech Pharmaceuticals: Supplied by Cross The Limits, an official UK distributor of Hi-Tech Pharmaceuticals.
  • Capsule Format: 30 capsules, taken as 1 daily in the morning or afternoon.

How Does Hi-Tech Halodrol Work?

Halodrol from Hi-tech Pharmaceuticals is a steroid product designed to increase muscle mass for athletes. The product reduces recovery time after training and increases muscle endurance. In addition, it increases vascularity and prevents water accumulation in the body. Halodrol is recommended for anyone who wants to get a distinct musculature. The way it works is similar to testosterone. It contains a 250 mg blend: 1-androstene-3b-ol, 17-one (1-Andro). 1-androstane-3b-ol is responsible for high muscle mass gain, and 1 Andro is an energy prohormone that produces 1 testosterone. The result of using 1-Andro is a high gain in muscle mass and improved testosterone production. 4-Andro, like 1-Andro, is involved in the conversion to testosterone. A mixture of 4 compounds transformed into solid anabolics is 200% more anabolic than testosterone. This is one of the best supplements to increase lean muscle mass and strength.

Reviews

There are no reviews yet.

Be the first to review “Hi-Tech Pharmaceuticals Halodrol”

Your email address will not be published. Required fields are marked *